Archives

by in
Entry Author Date Location
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Join Us for ‘Boston Biotech Seizes the Momentum’ on April 4 02/07/13 Boston
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
See You Today at New England’s Emerging Biotech Stars***SOLD OUT*** 04/04/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
New England’s Emerging Biotech Stars: The Agenda 03/08/12 Boston
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
Disease Foundations Play Growing Role in Biotech Business Model 03/06/12 San Francisco
Why Biogen Idec Got Out of the Corporate VC Business 01/27/12 Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event 01/26/12 Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News 09/02/11 Boston
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec 08/31/11 Boston
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News 07/22/11 Boston
Biogen Idec Moving HQ Back to Cambridge, Constructing Two New Buildings at Kendall Square 07/20/11 Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Biogen Idec CEO on Move Back to Cambridge: “We’re Working on It” 06/16/11 Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team 01/05/11 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Page 1 of 2 next page »